Results 141 to 150 of about 5,655 (219)

Dual-channel ultrasonic images empowered deep learning: significantly improving prediction of occult central lymph node metastases in solitary papillary thyroid microcarcinoma. [PDF]

Radiol Oncol
Li M, Jia C, Li G, Shi Q, Liu L.
europepmc   +1 more source

Ultrasound-based nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma. [PDF]

BMC Endocr Disord
Huang H, Hu L, Chen X, Luo H.
europepmc   +1 more source

Nomogram prediction for central lymph node metastasis in papillary thyroid microcarcinoma of the isthmus based on clinical and ultrasound features. [PDF]

Front Surg
Shi Y, Qian L, Huang J, Ma T, Cui X, Zhang J.   +5 more
europepmc   +1 more source

Recurrence risk of differentiated thyroid cancer treated with total or hemithyroidectomy: systematic review and meta-analysis. [PDF]

Eur Thyroid J
Piccardo A, Fiz F, Bottoni G, Treglia G, Trimboli P.   +4 more
europepmc   +1 more source

New gadgets for thyroid ablation-what's the promise? [PDF]

Gland Surg
Stan MN, Schmitz JJ.
europepmc   +1 more source

Clinicopathological landscape and management trends of thyroid carcinoma over two decades: a single-institution study and risk stratification of central lymph node metastasis in T1 papillary thyroid carcinoma. [PDF]

Front Endocrinol (Lausanne)
Qin L, Ke X, Nie Y, Zhu Y, Liu S, Wang J.   +5 more
europepmc   +1 more source

Risk Stratification in Papillary Thyroid Microcarcinoma: Clinical Features Predicting Multifocality, Lymph Node Metastasis, and Recurrence - A Retrospective Cohort Study. [PDF]

Cancer Manag Res
Hsu CC, Tsai CY, Lin LC, Wang SY, Yeh CN, Liou MJ, Chen ST.   +6 more
europepmc   +1 more source

Exploratory Statistical Analyses of Clinical and Biochemical Factors for Differentiated Thyroid Cancer from a Romanian Cohort. [PDF]

Cancers (Basel)
Dima A, Lixandru-Petre IO, Iorga D, Gradisteanu Pircalabioru G, Terzea DC, Goldstein A, Iliescu FS, Dascalu M, Musat M, Iliescu C.   +9 more
europepmc   +1 more source

Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer: Protocol of a Multicenter Cluster-Randomized Trial (MAeSTro-SDM). [PDF]

J Korean Med Sci
Lee EK, Kim MJ, Hwangbo Y, Moon JH, Cho SW, Chai YJ, Choi JY, Jung YS, Lee KE, Chung EJ, Kim K, Kim SJ, Kim W, Kim YH, Lee YK, Jang J, Song YS, Yi KH, Yu HW, Moon S, Jung KY, Kim HJ, Ryu CH, Ryu J, Seok J, Kang SH, Lee S, Chu AJ, Lee CY, Lee JY, Lim H, Kim JH, Park SK, Park YJ.   +33 more
europepmc   +1 more source

Diagnostic Significance of Trophoblast Cell Surface Antigen-2 Expression in Benign and Malignant Thyroid Lesions. [PDF]

Cureus
Jeneffar AQ, Anitharani S.
europepmc   +1 more source